• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

食物显著降低一线抗结核药物的血浆浓度。

Food significantly reduces plasma concentrations of first-line anti-tuberculosis drugs.

机构信息

Department of Biochemistry & Clinical Pharmacology, ICMR- National Institute for Research in Tuberculosis, Chennai, India.

Department of Statistics, ICMR- National Institute for Research in Tuberculosis, Chennai, India.

出版信息

Indian J Med Res. 2017 Apr;145(4):530-535. doi: 10.4103/ijmr.IJMR_552_15.

DOI:10.4103/ijmr.IJMR_552_15
PMID:28862186
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5663168/
Abstract

BACKGROUND & OBJECTIVES: Concomitant feeding and anti-tuberculosis (TB) drug administration are likely to reduce nausea and enhance compliance to treatment. However, food could lower plasma drug concentrations. This study was undertaken to examine the effect of food on two-hour plasma concentrations of rifampicin (RMP), isoniazid (INH) and pyrazinamide (PZA), and pharmacokinetics of these drugs in adult TB patients.

METHODS

Newly diagnosed adult TB patients were recruited from the Revised National Tuberculosis Control Programme (RNTCP) treatment centres in Chennai Corporation, Chennai, India. Two-hour post-dosing plasma concentrations were determined in 25 patients, and a semi-intensive pharmacokinetic study was undertaken in six patients. RMP, INH and PZA concentrations were determined by high-performance liquid chromatography.

RESULTS

The geometric mean two-hour concentrations with food and under fasting conditions were 2.2 and 5.5 μg/ml for RMP (P<0.001), 3.9 and 11.3 μg/ml for INH (P<0.001), and 18.0 and 28.2 μg/ml for PZA (P<0.001), respectively. Drug administration with food caused the plasma concentration to decrease by 50, 45 and 34 per cent for RMP, INH and PZA, respectively. Significant decreases in peak concentrations and exposures of drugs and delay in time to attain peak concentrations of drugs when taken with food were also observed.

INTERPRETATION & CONCLUSIONS: Our findings showed that food lowered anti-TB drug concentrations significantly and delayed absorption. Patients may be explained the beneficial effects of taking anti-TB drugs in a fasting state and advised to do so. There is a need for more research on optimization of dosing to maximize efficacy and safety of currently used drugs.

摘要

背景与目的

同时进食和给予抗结核(TB)药物可能会减轻恶心感并提高治疗依从性。然而,食物可能会降低血浆药物浓度。本研究旨在检测食物对成人肺结核患者利福平(RMP)、异烟肼(INH)和吡嗪酰胺(PZA)两小时血浆浓度以及这些药物药代动力学的影响。

方法

从印度钦奈市修正国家结核病控制规划(RNTCP)治疗中心招募新诊断的成人肺结核患者。在 25 名患者中测定了两小时后给药后的血浆浓度,并对 6 名患者进行了半强化药代动力学研究。通过高效液相色谱法测定 RMP、INH 和 PZA 浓度。

结果

进食和空腹状态下的两小时平均浓度分别为 RMP 2.2μg/ml 和 5.5μg/ml(P<0.001),INH 3.9μg/ml 和 11.3μg/ml(P<0.001),PZA 18.0μg/ml 和 28.2μg/ml(P<0.001)。与空腹相比,进食时 RMP、INH 和 PZA 的血浆浓度分别降低了 50%、45%和 34%。还观察到药物的峰浓度和暴露量显著降低,以及药物达到峰浓度的时间延迟。

解释与结论

我们的研究结果表明,食物显著降低了抗结核药物的浓度并延迟了吸收。可以向患者解释空腹服用抗结核药物的有益效果,并建议他们这样做。需要进一步研究优化剂量,以最大限度地提高目前使用药物的疗效和安全性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/28cc/5663168/9558030766fb/IJMR-145-530-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/28cc/5663168/9558030766fb/IJMR-145-530-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/28cc/5663168/9558030766fb/IJMR-145-530-g002.jpg

相似文献

1
Food significantly reduces plasma concentrations of first-line anti-tuberculosis drugs.食物显著降低一线抗结核药物的血浆浓度。
Indian J Med Res. 2017 Apr;145(4):530-535. doi: 10.4103/ijmr.IJMR_552_15.
2
Anti-tuberculosis drug concentrations in tuberculosis patients with and without diabetes mellitus.合并或未合并糖尿病的结核病患者的抗结核药物浓度
Eur J Clin Pharmacol. 2017 Jan;73(1):65-70. doi: 10.1007/s00228-016-2132-z. Epub 2016 Sep 20.
3
Pharmacokinetics of isoniazid, rifampicin, pyrazinamide and ethambutol in HIV-infected Indian children.异烟肼、利福平、吡嗪酰胺和乙胺丁醇在感染HIV的印度儿童中的药代动力学
Int J Tuberc Lung Dis. 2016 May;20(5):666-72. doi: 10.5588/ijtld.15.0288.
4
Pharmacokinetics of thrice-weekly rifampicin, isoniazid and pyrazinamide in adult tuberculosis patients in India.印度成年结核病患者中每周三次利福平、异烟肼和吡嗪酰胺的药代动力学
Int J Tuberc Lung Dis. 2016 Sep;20(9):1236-41. doi: 10.5588/ijtld.16.0048.
5
Isoniazid, rifampicin and pyrazinamide plasma concentrations 2 and 6 h post dose in patients with pulmonary tuberculosis.异烟肼、利福平及吡嗪酰胺在肺结核患者给药后 2 及 6 小时的血药浓度。
Int J Tuberc Lung Dis. 2013 Dec;17(12):1602-6. doi: 10.5588/ijtld.13.0019.
6
Age, nutritional status and INH acetylator status affect pharmacokinetics of anti-tuberculosis drugs in children.年龄、营养状况和异烟肼乙酰化状态影响儿童抗结核药物的药代动力学。
Int J Tuberc Lung Dis. 2013 Jun;17(6):800-6. doi: 10.5588/ijtld.12.0628.
7
Low Serum Concentrations of Rifampicin and Pyrazinamide Associated with Poor Treatment Outcomes in Children with Tuberculosis Related to HIV Status.血清中利福平和平吡嗪酰胺浓度低与合并人类免疫缺陷病毒感染的儿童结核病治疗效果不佳相关。
Pediatr Infect Dis J. 2016 May;35(5):530-4. doi: 10.1097/INF.0000000000001069.
8
Intrapatient variability in plasma rifampicin & isoniazid in tuberculosis patients.肺结核患者血浆利福平和异烟肼的个体内变异。
Indian J Med Res. 2018 Mar;147(3):287-292. doi: 10.4103/ijmr.IJMR_1961_16.
9
Pharmacokinetics of isoniazid, rifampin, and pyrazinamide in children younger than two years of age with tuberculosis: evidence for implementation of revised World Health Organization recommendations.异烟肼、利福平、吡嗪酰胺在 2 岁以下儿童结核病患者中的药代动力学:实施世界卫生组织修订建议的证据。
Antimicrob Agents Chemother. 2011 Dec;55(12):5560-7. doi: 10.1128/AAC.05429-11. Epub 2011 Oct 3.
10
Pharmacokinetics of first-line antituberculosis drugs in HIV-infected children with tuberculosis treated with intermittent regimens in India.印度采用间歇疗法治疗的合并结核病的HIV感染儿童中一线抗结核药物的药代动力学
Antimicrob Agents Chemother. 2015 Feb;59(2):1162-7. doi: 10.1128/AAC.04338-14. Epub 2014 Dec 8.

引用本文的文献

1
Nutritional Deficiencies and Management in Tuberculosis: Pharmacotherapeutic and Clinical Implications.结核病中的营养缺乏与管理:药物治疗及临床意义
Nutrients. 2025 May 30;17(11):1878. doi: 10.3390/nu17111878.
2
Knowledge, Attitude, and Practice Toward Antitubercular Agents Among Pulmonary Tuberculosis Patients in Southwestern China: A Cross-Sectional Study.中国西南部肺结核患者对抗结核药物的知识、态度及实践:一项横断面研究
Patient Prefer Adherence. 2025 May 30;19:1615-1624. doi: 10.2147/PPA.S520100. eCollection 2025.
3
The Development of an Age-Appropriate Fixed Dose Combination for Tuberculosis Using Physiologically-Based Pharmacokinetic Modeling (PBBM) and Risk Assessment.

本文引用的文献

1
Factors Influencing Tuberculosis Treatment Outcome in Adult Patients Treated with Thrice-Weekly Regimens in India.印度采用每周三次治疗方案的成年肺结核患者治疗结果的影响因素
Antimicrob Agents Chemother. 2017 Apr 24;61(5). doi: 10.1128/AAC.02464-16. Print 2017 May.
2
Effects of dosage, comorbidities, and food on isoniazid pharmacokinetics in Peruvian tuberculosis patients.剂量、合并症及食物对秘鲁结核病患者异烟肼药代动力学的影响。
Antimicrob Agents Chemother. 2014 Dec;58(12):7164-70. doi: 10.1128/AAC.03258-14. Epub 2014 Sep 15.
3
Impact of food intake on the pharmacokinetics of first-line antituberculosis drugs in Taiwanese tuberculosis patients.
使用基于生理学的药代动力学模型(PBBM)和风险评估开发适合年龄的结核病固定剂量复方制剂。
Pharmaceutics. 2024 Dec 12;16(12):1587. doi: 10.3390/pharmaceutics16121587.
4
Therapeutic drug monitoring in tuberculosis.结核病治疗药物监测。
Eur J Clin Pharmacol. 2024 Nov;80(11):1659-1684. doi: 10.1007/s00228-024-03749-8. Epub 2024 Sep 6.
5
Precision Medicine Strategies to Improve Isoniazid Therapy in Patients with Tuberculosis.精准医学策略改善结核病患者的异烟肼治疗。
Eur J Drug Metab Pharmacokinet. 2024 Sep;49(5):541-557. doi: 10.1007/s13318-024-00910-7. Epub 2024 Aug 17.
6
Breaking barriers: The potential of nanosystems in antituberculosis therapy.突破障碍:纳米系统在抗结核治疗中的潜力
Bioact Mater. 2024 May 17;39:106-134. doi: 10.1016/j.bioactmat.2024.05.013. eCollection 2024 Sep.
7
Effect of Food Composition on the PK of Isoniazid Quantitatively Explained Using Physiologically Based Biopharmaceutics Modeling.基于生理的药代动力学模型定量解释食物成分对异烟肼药代动力学的影响。
AAPS J. 2024 Apr 24;26(3):54. doi: 10.1208/s12248-024-00923-9.
8
"It is not easy": Experiences of people living with HIV and tuberculosis on Tuberculosis treatment in Uganda.“这并不容易”:乌干达感染艾滋病毒和结核病患者的结核病治疗经历
J Clin Tuberc Other Mycobact Dis. 2023 Jun 21;33:100385. doi: 10.1016/j.jctube.2023.100385. eCollection 2023 Dec.
9
Real-world impact of the fixed-dose combination on improving treatment outcomes of drug-susceptible tuberculosis: a comparative study using multiyear national tuberculosis patient data.固定剂量复方药物对改善耐多药结核病治疗结局的真实世界影响:基于多年全国结核病患者数据的对比研究。
BMJ Open Respir Res. 2023 Nov;10(1). doi: 10.1136/bmjresp-2023-001758.
10
Correlation of N-acetyltransferase 2 genotype and acetylation status with plasma isoniazid concentration and its metabolic ratio in ethiopian tuberculosis patients.乙酰转移酶 2 基因型和乙酰化状态与埃塞俄比亚结核病患者血浆异烟肼浓度及其代谢比值的相关性。
Sci Rep. 2023 Jul 15;13(1):11438. doi: 10.1038/s41598-023-38716-3.
食物摄入对台湾结核病患者一线抗结核药物药代动力学的影响。
J Formos Med Assoc. 2014 May;113(5):291-7. doi: 10.1016/j.jfma.2014.01.015. Epub 2014 Mar 1.
4
Serum drug concentrations predictive of pulmonary tuberculosis outcomes.预测肺结核结局的血清药物浓度。
J Infect Dis. 2013 Nov 1;208(9):1464-73. doi: 10.1093/infdis/jit352. Epub 2013 Jul 29.
5
Pharmacokinetic/pharmacodynamic parameters and the choice of high-dosage rifamycins.药代动力学/药效学参数与高剂量利福霉素的选择。
Int J Tuberc Lung Dis. 2012 Sep;16(9):1186-9. doi: 10.5588/ijtld.11.0818. Epub 2012 Jul 12.
6
Impact of food and antacids on the pharmacokinetics of anti-tuberculosis drugs: systematic review and meta-analysis.食物和抗酸剂对抗结核药物药代动力学的影响:系统评价和荟萃分析。
Int J Tuberc Lung Dis. 2010 Jul;14(7):806-18.
7
In vitro evaluation of food effect on the bioavailability of rifampicin from antituberculosis fixed dose combination formulations.食物对抗结核固定剂量复方制剂中利福平生物利用度影响的体外评价
Farmaco. 2003 Nov;58(11):1099-103. doi: 10.1016/S0014-827X(03)00161-7.
8
Therapeutic drug monitoring in the treatment of tuberculosis.结核病治疗中的治疗药物监测
Drugs. 2002;62(15):2169-83. doi: 10.2165/00003495-200262150-00001.
9
Ofloxacin population pharmacokinetics in patients with tuberculosis.氧氟沙星在肺结核患者中的群体药代动力学。
Int J Tuberc Lung Dis. 2002 Jun;6(6):503-9. doi: 10.5588/09640569513011.
10
Pharmacokinetics of isoniazid under fasting conditions, with food, and with antacids.空腹状态下、与食物同服时以及与抗酸剂同服时异烟肼的药代动力学。
Int J Tuberc Lung Dis. 1999 Aug;3(8):703-10.